Literature DB >> 32229037

Incidence of chronic kidney disease in patients with non-alcoholic fatty liver disease.

Zi-Yuan Zou1, Jian-Gao Fan2.   

Abstract

Entities:  

Year:  2020        PMID： 32229037     DOI： 10.1016/j.jhep.2020.03.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

Review 1.  Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease.

Authors:  Ziwen Tao; Yueyue Li; Baoquan Cheng; Tao Zhou; Yanjing Gao
Journal:  J Clin Transl Hepatol       Date:  2021-09-22

2.  Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.

Authors:  Beihui He; Zheng Chen; Yunmeng Nie; Minmin Luo; Sumei Xu; Junbin Yan; Zhiyun Chen
Journal:  J Immunol Res       Date:  2022-06-12       Impact factor: 4.493

3.  Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease.

Authors:  Chang-Hai Liu; Shanshan Zheng; Shisheng Wang; Dongbo Wu; Wei Jiang; Qingmin Zeng; Yi Wei; Yong Zhang; Hong Tang
Journal:  Diagnostics (Basel)       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.